Indication:
OriliTM 200 tablet is indicated for the management of moderate to severe pain associated with endometriosis.
Dosage & Administration:
Pregnancy should be excluded before starting treatment with elagolix and start elagolix within 7 days from the onset of menses. Initial treatment with elagolix 200 mg twice daily up to 6 months (with coexisting dyspareunia). Treatment with elagolix 200 mg should not exist more than 6 months as it may decrease bone mineral density (BMD). In case of moderate to severe hepatic impairment elagolix 200 mg is not recommended.
Preparation:
Each box contains 12 tablets in alu-alu blister strip.
